Kuo Ting-Yu, Hong Zhi-Wei, Tsai Chung-Che, Yang Yu-Chi, Fu Hua-Wen
Institute of Molecular and Cellular Biology, National Tsing Hua University.
Institute of Molecular and Cellular Biology, National Tsing Hua University; Department of Life Science, National Tsing Hua University;
J Vis Exp. 2016 Jun 18(112):54043. doi: 10.3791/54043.
Helicobacter pylori neutrophil-activating protein (HP-NAP) is a major virulence factor of Helicobacter pylori (H. pylori). It plays a critical role in H. pylori-induced gastric inflammation by activating several innate leukocytes including neutrophils, monocytes, and mast cells. The immunogenic and immunomodulatory properties of HP-NAP make it a potential diagnostic and vaccine candidate for H. pylori and a new drug candidate for cancer therapy. In order to obtain substantial quantities of purified HP-NAP used for its clinical applications, an efficient method to purify this protein with high yield and purity needs to be established. In this protocol, we have described a method for one-step negative chromatographic purification of recombinant HP-NAP overexpressed in Escherichia coli (E. coli) by using diethylaminoethyl (DEAE) ion-exchange resins (e.g., Sephadex) in batch mode. Recombinant HP-NAP constitutes nearly 70% of the total protein in E. coli and is almost fully recovered in the soluble fraction upon cell lysis at pH 9.0. Under the optimal condition at pH 8.0, the majority of HP-NAP is recovered in the unbound fraction while the endogenous proteins from E. coli are efficiently removed by the resin. This purification method using negative mode batch chromatography with DEAE ion-exchange resins yields functional HP-NAP from E. coli in its native form with high yield and purity. The purified HP-NAP could be further utilized for the prevention, treatment, and prognosis of H. pylori-associated diseases as well as cancer therapy.
幽门螺杆菌中性粒细胞激活蛋白(HP-NAP)是幽门螺杆菌(H. pylori)的一种主要毒力因子。它通过激活包括中性粒细胞、单核细胞和肥大细胞在内的多种先天性白细胞,在幽门螺杆菌诱导的胃部炎症中发挥关键作用。HP-NAP的免疫原性和免疫调节特性使其成为幽门螺杆菌潜在的诊断和疫苗候选物以及癌症治疗的新药候选物。为了获得大量用于临床应用的纯化HP-NAP,需要建立一种高效的方法来高产率、高纯度地纯化这种蛋白质。在本方案中,我们描述了一种通过使用二乙氨基乙基(DEAE)离子交换树脂(如葡聚糖凝胶)以分批模式对在大肠杆菌(E. coli)中过表达的重组HP-NAP进行一步负相色谱纯化的方法。重组HP-NAP占大肠杆菌总蛋白的近70%,在pH 9.0下细胞裂解后几乎完全回收在可溶部分中。在pH 8.0的最佳条件下,大部分HP-NAP回收在未结合部分,而大肠杆菌的内源性蛋白质则被树脂有效去除。这种使用DEAE离子交换树脂的负相分批色谱纯化方法能够以高产率和高纯度从大肠杆菌中获得天然形式的功能性HP-NAP。纯化后的HP-NAP可进一步用于幽门螺杆菌相关疾病的预防、治疗和预后以及癌症治疗。